Jessica Herzig/LinkedIn
Dec 21, 2025, 13:54
Jessica Herzig on CD86 Expression Correlation with Immune Cell Activation
RPTH Journal shared on LinkedIn:
”Why do some hemophilia A patients develop inhibitors?
This study points to immune activation patterns that depend more on timing, even seasonality, than on the FVIII product itself.
Check out this fascinating study by Jessica Herzig and team here.”
Article: Season-dependent low basal CD86 expression promotes immune cell activation upon treatment with plasma-derived factor Ⅷ products
Authors: Jessica Herzig, Josselyn Azucena Arciniega Martinez, Svenja M. Küster, Eva Ringler, Stefanie Kronhart, Gerrit J. K. Praefcke, Lilija Miller, Martina Anzaghe, Zoe Waibler
Stay updated on all scientific advances with Hemostasis Today.
-
May 6, 2026, 18:03Shiv Choudhary: Did You Know That Varicose Veins Can Be Detected with a Simple Test?
-
May 6, 2026, 17:48A Hidden Mechanical Cause of Recurrent Thrombosis in a Young Athlete – The Lancet
-
May 6, 2026, 17:26Joanna Fraser: Highlights from WFH Congress 2026 in Malaysia
-
May 6, 2026, 17:04Nour Al-Mozain: Massive Transfusion in Pediatrics
-
May 6, 2026, 16:36Ney Carter Borges: Randomized Trial of the Vascular Effects of Low-Dose Colchicine in High-Risk Type 2 Diabetes
-
May 6, 2026, 16:35Giuseppe Lippi: Essential Laboratory Testing in Emergencies
-
May 6, 2026, 16:28Anna-Maria Tsilia: Addressing Psychological Aspects of Hemophilia at WFH 2026
-
May 6, 2026, 16:24Elena Donoso Úbeda: Attending WFH 2026 for Manual Therapy Workshop and Global Collaboration
-
May 6, 2026, 16:22Dhamirah Nazihah Mohd Nasiruddin: Reflecting on a Transformative Fellowship in Haemostasis and Thrombosis at Barts Health